Literature DB >> 27393411

Immunological aspects of congenital disorders of glycosylation (CDG): a review.

Maria Monticelli1,2, Tiago Ferro1,3, Jaak Jaeken4,5, Vanessa Dos Reis Ferreira6,7, Paula A Videira8,9,10.   

Abstract

Congenital disorders of glycosylation (CDG) are a rapidly growing family of genetic diseases comprising more than 85 known distinct disorders. They show a great phenotypic variability ranging from multi-organ/system to mono-organ/system involvement with very mild to extremely severe expression. Immunological dysfunction has a significant impact on the phenotype in a minority of CDG. CDG with major immunological involvement are ALG12-CDG, MAGT1-CDG, MOGS-CDG, SLC35C1-CDG and PGM3-CDG. This review discusses the variety of immunological abnormalities reported in human CDG. Understanding the immunological aspects of CDG may contribute to a better management/treatment of these pathologies and possibly of more common diseases, such as inflammatory diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27393411     DOI: 10.1007/s10545-016-9954-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.750


  115 in total

1.  Association of fungal sepsis and galactosemia.

Authors:  Sanjay Verma; Bhavneet Bharti; P Inusha
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

2.  N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency.

Authors:  Radka Saldova; Henning Stöckmann; Roisin O'Flaherty; Dirk J Lefeber; Jaak Jaeken; Pauline M Rudd
Journal:  J Proteome Res       Date:  2015-09-24       Impact factor: 4.466

3.  Congenital disorder of glycosylation (CDG) Ig: report on a patient and review of the literature.

Authors:  M Di Rocco; T Hennet; C E Grubenmann; S Pagliardini; A E M Allegri; C G Frank; M Aebi; S Vignola; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency.

Authors:  Monique Van Scherpenzeel; Sharita Timal; Daisy Rymen; Alexander Hoischen; Manfred Wuhrer; Agnes Hipgrave-Ederveen; Stephanie Grunewald; Romain Peanne; Ann Saada; Shimon Edvardson; Sabine Grønborg; George Ruijter; Anna Kattentidt-Mouravieva; Jaime Moritz Brum; Mary-Louise Freckmann; Susan Tomkins; Anil Jalan; Dagmar Prochazkova; Nina Ondruskova; Hana Hansikova; Michel A Willemsen; Paul J Hensbergen; Gert Matthijs; Ron A Wevers; Joris A Veltman; Eva Morava; Dirk J Lefeber
Journal:  Brain       Date:  2014-02-24       Impact factor: 13.501

5.  Pericardial and abdominal fluid accumulation in congenital disorder of glycosylation type Ia.

Authors:  Gerben Truin; Mailys Guillard; Dirk J Lefeber; Jolanta Sykut-Cegielska; Maciej Adamowicz; Esther Hoppenreijs; Rob C A Sengers; Ron A Wevers; Eva Morava
Journal:  Mol Genet Metab       Date:  2008-06-20       Impact factor: 4.797

6.  Congenital disorder of glycosylation Ia: new differentially expressed proteins identified by 2-DE.

Authors:  Eva Richard; Ana I Vega; Belén Pérez; Carmen Roche; Ramón Velázquez; Magdalena Ugarte; Celia Pérez-Cerdá
Journal:  Biochem Biophys Res Commun       Date:  2008-12-25       Impact factor: 3.575

7.  Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.

Authors:  Atfa Sassi; Sandra Lazaroski; Gang Wu; Stuart M Haslam; Manfred Fliegauf; Fethi Mellouli; Turkan Patiroglu; Ekrem Unal; Mehmet Akif Ozdemir; Zineb Jouhadi; Khadija Khadir; Leila Ben-Khemis; Meriem Ben-Ali; Imen Ben-Mustapha; Lamia Borchani; Dietmar Pfeifer; Thilo Jakob; Monia Khemiri; A Charlotta Asplund; Manuela O Gustafsson; Karin E Lundin; Elin Falk-Sörqvist; Lotte N Moens; Hatice Eke Gungor; Karin R Engelhardt; Magdalena Dziadzio; Hans Stauss; Bernhard Fleckenstein; Rebecca Meier; Khairunnadiya Prayitno; Andrea Maul-Pavicic; Sandra Schaffer; Mirzokhid Rakhmanov; Philipp Henneke; Helene Kraus; Hermann Eibel; Uwe Kölsch; Sellama Nadifi; Mats Nilsson; Mohamed Bejaoui; Alejandro A Schäffer; C I Edvard Smith; Anne Dell; Mohamed-Ridha Barbouche; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2014-04-01       Impact factor: 10.793

Review 8.  Dendritic cells: a spot on sialic Acid.

Authors:  Hélio J Crespo; Joseph T Y Lau; Paula A Videira
Journal:  Front Immunol       Date:  2013-12-27       Impact factor: 7.561

9.  MAN1B1 deficiency: an unexpected CDG-II.

Authors:  Daisy Rymen; Romain Peanne; María B Millón; Valérie Race; Luisa Sturiale; Domenico Garozzo; Philippa Mills; Peter Clayton; Carla G Asteggiano; Dulce Quelhas; Ali Cansu; Esmeralda Martins; Marie-Cécile Nassogne; Miguel Gonçalves-Rocha; Haluk Topaloglu; Jaak Jaeken; François Foulquier; Gert Matthijs
Journal:  PLoS Genet       Date:  2013-12-12       Impact factor: 5.917

10.  GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients.

Authors:  Maria E de la Morena-Barrio; Trinidad Hernández-Caselles; Javier Corral; Roberto García-López; Irene Martínez-Martínez; Belen Pérez-Dueñas; Carmen Altisent; Teresa Sevivas; Soren R Kristensen; Encarna Guillén-Navarro; Antonia Miñano; Vicente Vicente; Jaak Jaeken; Maria L Lozano
Journal:  Orphanet J Rare Dis       Date:  2013-10-20       Impact factor: 4.123

View more
  21 in total

1.  Identification and characterization of novel mutations in MOGS in a Chinese patient with infantile spams.

Authors:  Xuehua Peng; Sukun Luo; Yufeng Huang; Li Tan; Jianbo Shao; Xuelian He
Journal:  Neurogenetics       Date:  2020-01-10       Impact factor: 2.660

Review 2.  What is new in CDG?

Authors:  Jaak Jaeken; Romain Péanne
Journal:  J Inherit Metab Dis       Date:  2017-05-08       Impact factor: 4.982

Review 3.  Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature.

Authors:  D Marques-da-Silva; V Dos Reis Ferreira; M Monticelli; P Janeiro; P A Videira; P Witters; J Jaeken; D Cassiman
Journal:  J Inherit Metab Dis       Date:  2017-01-20       Impact factor: 4.982

Review 4.  Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature.

Authors:  D Marques-da-Silva; R Francisco; D Webster; V Dos Reis Ferreira; J Jaeken; T Pulinilkunnil
Journal:  J Inherit Metab Dis       Date:  2017-07-19       Impact factor: 4.982

5.  Recombinant Proteins and Monoclonal Antibodies.

Authors:  Roy Jefferis
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

6.  Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins.

Authors:  Yoo Jung Choi; Jinhui Zhu; Steve Chung; Naveed Siddiqui; Qingping Feng; Peter B Stathopulos
Journal:  J Vis Exp       Date:  2017-10-04       Impact factor: 1.355

7.  ALG12-CDG: novel glycophenotype insights endorse the molecular defect.

Authors:  Luisa Sturiale; Sebastiano Bianca; Domenico Garozzo; Alessandra Terracciano; Emanuele Agolini; Angela Messina; Angelo Palmigiano; Francesca Esposito; Chiara Barone; Antonio Novelli; Agata Fiumara; Jaak Jaeken; Rita Barone
Journal:  Glycoconj J       Date:  2019-09-16       Impact factor: 2.916

8.  A Novel Homozygous ALG12 Mutation in a Patient with CDG Type Ig: New Report of a Case with a Mild Phenotype.

Authors:  Antonio Gennaro Nicotera; Giulia Spoto; Francesco Calì; Giusi Romeo; Antonino Musumeci; Mirella Vinci; Agata Fiumara; Rita Barone; Gabriella Di Rosa; Sebastiano Antonino Musumeci
Journal:  Mol Syndromol       Date:  2021-07-20

Review 9.  Glycosylation in health and disease.

Authors:  Colin Reily; Tyler J Stewart; Matthew B Renfrow; Jan Novak
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 42.439

10.  A genome-wide CRISPR screen reconciles the role of N-linked glycosylation in galectin-3 transport to the cell surface.

Authors:  Sarah E Stewart; Sam A Menzies; Stephanie J Popa; Natalia Savinykh; Anna Petrunkina Harrison; Paul J Lehner; Kevin Moreau
Journal:  J Cell Sci       Date:  2017-08-03       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.